Products

Capillary.io

Capillary.io - Web application that simplifies and automates nailfold capillaroscopy with artificial intelligence

capillary.io Health & Wellness / Symptom Checkers & Medical AI

AI Benchmark
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Eduardo Ramos Ibáñez
@eduramiba· 285 followers+1 more creators
Launched
5y ago
2021-07-28 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Capillaroscopy made quick, simple and objective

    Jul 28, 2021 · 5y agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Organic Search36%
  • Direct24%
  • Display Ads9%
  • Referrals8%
  • Other23%

Countries

  • United States84%
  • Spain16%

Search

Domain authority —Domain registered 2018-07-13

KeywordMonthly volume
capi38K
capillary18.8K
nailfold capillaroscopy1,280
capillary loops1,130
cappillari1,110

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2021-07-28

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Capillary.io get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Capillary.io and what platforms does it support?
Capillary.io is catalogued under Symptom Checkers & Medical AI: Capillary.io - Web application that simplifies and automates nailfold capillaroscopy with artificial intelligence. Supported platforms: Web.

Related products in this category

Health & Wellness / Symptom Checkers & Medical AI

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.